SCHEMBL4604357

SCHEMBL4604357

COc1cc(CN)ccc1-c1nc2ccccc2s1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
KDM4E B2RXH2 6/20 0.65
MEN1 O00255 5/20 0.65
KMT2A Q03164 5/20 0.65
MAPT P10636 5/20 0.65
GAA P10253 3/20 0.65
HCRTR1 O43613 2/20 0.65
GLA P06280 2/20 0.65
SMN1; SMN2 Q16637 6/20 0.54
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
EGFR P00533 4/20 0.51
TEK Q02763 3/20 0.51
IGF1R P08069 2/20 0.51
ERBB2 P04626 1/20 0.51
HPGD P15428 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
PKM P14618 1/20 0.50
PPARG P37231 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1983245 0.83 MEN1 (0.70) ALDH1A1KDM4EMEN1KMT2AMAPT
Methyl Alcohol SCHEMBL27724944 0.82 MAPT (0.63) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL27745773 0.81 RAB9A (0.67) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL15454599 0.81 MAPT (0.72) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL27724954 0.80 MAPT (0.65) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL30161844 0.79 ALDH1A1 (0.76) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL2088159 0.79 ALDH1A1 (0.76) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL19445043 0.78 MAPT (0.81) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL4604363 0.78 MAPT (0.67) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL28158582 0.77 MAPT (0.68) ALDH1A1KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910349-A1 2-ARYLBENZOTHIAZOLES AND USES THEREOF 4SC AG (DE) 2008-04-16 EP disclosed
WO-2007009524-A1 2-ARYLBENZOTHIAZOLES AND USES THEREOF 4SC AG (DE) 2007-01-25 WO disclosed
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof 4SC AG (DE) 2007-01-25 US disclosed
EP-1746096-A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer 4SC AG (DE) 2007-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof NR2E1, NR2E3, NR0B2 ALDH1A1 1173/4885KDM4E 2243/4885MEN1 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.